New Merck office boasts ‘future-proof’ technology

Merck has unveiled its new Sydney office at an official opening in the ‘innovation hub’ of Macquarie Park.

The company joins 180 large international and 200 small businesses in the Macquarie Park Innovation District.

The move to 11 Talavera Road is aimed at furthering Merck’s growth, capabilities and business partnerships and brings together – for the first time in one location – more than 120 Sydney employees from the company’s healthcare and life science divisions.

The colocation of healthcare and life science divisions at the office will facilitate collaboration, with the move designed to expand Merck’s local research and partnership potential in diverse growth areas, according to the science and technology company.

The office’s technology is described as “future-proof”, with a significant investment in secure connectivity made to enable “failsafe” internal and external (B2B) communications, according to Merck.

The design is said to prioritise workplace connectivity, employee wellbeing and the environment.

The 30 combined meeting and collaboration spaces, both formal and informal, are in a range of shapes and sizes in an ‘activity-based working’ style, supporting the wide variety of work conducted in a day, the company says.

Merck claims to be among the first science and technology companies in Australia to adopt this approach to working.

The opening included a showcase of the diverse range of products and services provided by Merck’s three divisions – healthcare, life science and performance materials.

The office was formally opened by federal MP for Bennelong John Alexander, and Dr Frank Stangenberg-Haverkamp, Chair of the Executive Board and the Family Board of E Merck KG.

“This is an exciting time as life science comes together with healthcare under one roof to further drive the success of our businesses, and of the wider scientific community, demonstrating that Merck is truly a vibrant science and technology company,” Merck Life Science Managing Director for Australia/New Zealand Bradley Simpson said.

Check Also

Pharmacists answer to GP shortfall issue

Forecasting a shortfall of GPs, Deloitte’s latest report highlights the need for pharmacists to take …